Patriots 'optimistic' Rob Gronkowski will be cleared to play in Super Bowl

Share

The Jacksonville Jaguars safety hit Gronk, and made helmet-to-helmet contact on the tight end, who got up slowly after the play. He left the game before the Patriots scored a touchdown on a one-yard run.

Church was penalized for a helmet-to-helmet hit, while Gronkowski exited the game to get evaluated for a possible concussion and didn't return.

The All-Pro stayed on the turf for a few seconds before getting to his feet.

Tight end Rob Gronkowski was knocked out of the?

Backed Kurdish forces plead with Washington to stop Turkish attack on Afrin
Turkish police prevent protests against the operation in Istanbul and Diyarbakir, a Kurdish stronghold in Turkey's southeast. The Kurds always get betrayed because what they really want is an independent Kurdistan including all 20 million Kurds.

After the Patriots home win against the Jaguars, Patricia shared an emotional celebration with his wife Raina and rolled in the confetti with his children.

The immediate aftermath of the hit was frightening, with Gronkowski unable to gain his footing and appearing to be dazed.

Church was whistled for an unnecessary roughness penalty.

Gronkowski presents the biggest matchup problem on the entire Patriots' offense, and nearly in arguably in the entire NFL. That might impact the league's media day, but the Patriots are clearly hopeful he'll be back on the field in two weeks. If I go low at his knees, it's a dirty play. It's a bang-bang play, and I was just trying to play football.

Juno Therapeutics (JUNO) Shares Skyrocket on Celgene Buyout
Separately, on January 18, Maxim's Jason McCarthy assigned a Buy rating to the stock and has a price target of $98. Juno Therapeutics had a negative net margin of 332.05% and a negative return on equity of 32.54%.

Tom Brady floated a ball to Gronkowski down the seam of the field.

"I just tried to dislodge the ball", Church said.

The hit took place right before the game went to halftime. It was a tough call, but you have to go with what they call. "It was a tough shot he took, and he's as tough as they come, so hopefully he feels better soon".

France's Sanofi Buys US Hemophilia Specialist Bioverativ
The biotechnology company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.55 by $0.25. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

Share